|
74 Companies |
|
57 Products |
|
57 Products |
|
42 Mechanisms of Action |
|
2 Trials |
|
680 News |
|
| «12...234567891011121314» |
- ||||||| Trial completion: Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo (clinicaltrials.gov) - Sep 2, 2013
P2/3, N=328, Completed, Sponsor: Galderma
Recruiting --> Completed
- Trial termination: Herpevac Neonatal Substudy (clinicaltrials.gov) - Aug 28, 2013
P=N/A, N=6, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Completed --> Terminated
- | Cubicin (daptomycin) / Merck (MSD)
Enrollment change, Gram positive: Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections (clinicaltrials.gov) - Aug 26, 2013
P4, N=420, Suspended, Sponsor: Cubist Pharmaceuticals
Completed --> Terminated N=339 --> 420
- amphotericin b liposome / Generic mfg.
Trial withdrawal, Combination therapy: SCH708980 With and Without AmBisome for Visceral Leishmaniasis (clinicaltrials.gov) - Aug 25, 2013
P1/2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=339 --> 420 Not yet recruiting --> Withdrawn
- amphotericin b liposome / Generic mfg.
Enrollment change, Combination therapy: SCH708980 With and Without AmBisome for Visceral Leishmaniasis (clinicaltrials.gov) - Aug 25, 2013
P1/2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Withdrawn N=90 --> 0
- | Ossirene (AS101) / Cassiopea, Feramda
Trial completion: Safety and Efficacy Study to Test Topical AS101 for External Genital Warts (clinicaltrials.gov) - Aug 13, 2013
P1/2, N=12, Completed, Sponsor: BioMAS Ltd
N=90 --> 0 Recruiting --> Completed
- terbinafine HCL / Generic mfg.
Clinical: Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis (clinicaltrials.gov) - Aug 7, 2013
P=N/A, N=30, Recruiting, Sponsor: Cambridge Health Alliance
- voriconazole / Generic mfg.
Trial termination: A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children (clinicaltrials.gov) - Aug 4, 2013
P3, N=31, Terminated, Sponsor: Pfizer
Recruiting --> Completed Recruiting --> Terminated; This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any safety issues or concerns.
- Trial termination: Sonographic Features of Cellulitis and Failure of Therapy (clinicaltrials.gov) - Jul 22, 2013
P=N/A, N=3, Terminated, Sponsor: University of Massachusetts, Worcester
Recruiting --> Terminated; This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any safety issues or concerns. Not yet recruiting --> Terminated; Unable to enroll significant number of patients.
- Enrollment change: Sonographic Features of Cellulitis and Failure of Therapy (clinicaltrials.gov) - Jul 22, 2013
P=N/A, N=3, Terminated, Sponsor: University of Massachusetts, Worcester
Not yet recruiting --> Terminated; Unable to enroll significant number of patients. N=153 --> 3
- |||| thimerosal (BTL-TML) / Beech Tree Labs
Enrollment open: Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores (clinicaltrials.gov) - Jul 17, 2013
P2, N=250, Recruiting, Sponsor: Beech Tree Labs, Inc.
N=153 --> 3 Not yet recruiting --> Recruiting
- ||||| thimerosal (BTL-TML) / Beech Tree Labs
New P2 trial: Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores (clinicaltrials.gov) - Jul 16, 2013
P2, N=250, Recruiting, Sponsor: Beech Tree Labs, Inc.
- Trial completion: Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Jul 15, 2013
P1, N=36, Completed, Sponsor: Infectious Disease Research Institute
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion: The Healthcare Professionals and the Leishmaniasis (clinicaltrials.gov) - Jul 7, 2013
P=N/A, N=228, Completed, Sponsor: Centro de Pesquisas René Rachou
Active, not recruiting --> Completed Not yet recruiting --> Completed
- Kineret (anakinra) / SOBI
Trial completion: Anakinra as a Treatment for Hydradenitis Suppurativa (clinicaltrials.gov) - Jul 4, 2013
P2, N=6, Completed, Sponsor: University of California, San Francisco
Not yet recruiting --> Completed Recruiting --> Completed
- | otesaconazole (VT-1161) / Mycovia Pharma
New P2 trial: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis (clinicaltrials.gov) - Jul 1, 2013
P2, N=48, Active, not recruiting, Sponsor: Viamet Pharmaceuticals, Inc.
- | acyclovir / Generic mfg.
Enrollment closed: Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia (clinicaltrials.gov) - Jun 25, 2013
P3, N=112, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
Recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment closed: An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) (clinicaltrials.gov) - Jun 24, 2013
P2, N=0, Active, not recruiting, Sponsor: Moberg Derma AB
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- voriconazole / Generic mfg.
New P2 trial: Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy (clinicaltrials.gov) - Jun 24, 2013
P2, N=33, Not yet recruiting, Sponsor: Colin Lunt
- |||||||||| Naftin (naftifine hydrochloride) / Merz Pharma
New P3 trial: Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris (clinicaltrials.gov) - Jun 20, 2013
P3, N=65, Completed, Sponsor: Merz Pharmaceuticals, LLC
- || valacyclovir / Generic mfg.
Trial completion: Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients (clinicaltrials.gov) - Jun 19, 2013
P3, N=40, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| AMG 108 / AstraZeneca
Enrollment open: Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa (clinicaltrials.gov) - Jun 12, 2013
P2a, N=100, Recruiting, Sponsor: AstraZeneca
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | Stelara (ustekinumab) / J&J
Enrollment closed: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa (clinicaltrials.gov) - Jun 12, 2013
P2, N=20, Active, not recruiting, Sponsor: University Medical Centre Groningen
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||||| Kerydin (tavaborole) / Pfizer
Trial completion: Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail (clinicaltrials.gov) - Jun 10, 2013
P3, N=604, Completed, Sponsor: Anacor Pharmaceuticals, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||||| Kerydin (tavaborole) / Pfizer
Trial completion: Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail (clinicaltrials.gov) - Jun 10, 2013
P3, N=594, Completed, Sponsor: Anacor Pharmaceuticals, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Trial completion: Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice (clinicaltrials.gov) - Jun 9, 2013
P2/3, N=30, Completed, Sponsor: Taro Pharmaceuticals USA
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Cresemba (isavuconazonium sulfate) / Astellas, Basilea, Pfizer, Laboratoire Riva, Asahi Kasei
Enrollment change: VITAL: Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi (clinicaltrials.gov) - Jun 5, 2013
P3, N=150, Active, not recruiting, Sponsor: Astellas Pharma Inc
Active, not recruiting --> Completed N=100 --> 150
- Altabax (retapamulin) / GSK, Almirall
Trial completion: United States Pharmacovigilence Retapamulin-Prescribing (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=1, Completed, Sponsor: GlaxoSmithKline
N=100 --> 150 Active, not recruiting --> Completed
- | isotretinoin oral / Generic mfg.
New P1 trial: Bioequivalence Study for an Isotretinoin (clinicaltrials.gov) - May 27, 2013
P1, N=36, Completed, Sponsor: GlaxoSmithKline
- | voriconazole / Generic mfg.
Trial completion: Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection (clinicaltrials.gov) - May 19, 2013
P2, N=21, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P2/3 trial: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - May 16, 2013
P2/3, N=20, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- ||| Enrollment change: Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail (clinicaltrials.gov) - May 14, 2013
P2, N=443, Completed, Sponsor: NanoBio Corporation
Active, not recruiting --> Completed N=1000 --> 443
- ||| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
Enrollment closed: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis (clinicaltrials.gov) - May 9, 2013
P2b, N=300, Active, not recruiting, Sponsor: Topica Pharmaceuticals
N=1000 --> 443 Recruiting --> Active, not recruiting
- Enrollment closed: The Role of Genital Warts in HIV Acquisition in Peru (clinicaltrials.gov) - May 9, 2013
P=N/A, N=600, Active, not recruiting, Sponsor: University of California, Los Angeles
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | New P1/2 trial: Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia (clinicaltrials.gov) - May 1, 2013
P1/2, N=80, Recruiting, Sponsor: Drugs for Neglected Diseases
- | ketoconazole / Generic mfg.
Enrollment change: An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot (clinicaltrials.gov) - Apr 30, 2013
P3, N=583, Terminated, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting --> Active, not recruiting N=466 --> 583
- |||| tigecycline / Generic mfg.
Enrollment open: TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) - Apr 28, 2013
P4, N=100, Enrolling by invitation, Sponsor: Pfizer
N=466 --> 583 Active, not recruiting --> Enrolling by invitation
- ||||||| Cresemba (isavuconazonium sulfate) / Astellas, Basilea, Pfizer, Laboratoire Riva, Asahi Kasei
Trial completion: SECURE: Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis (clinicaltrials.gov) - Apr 25, 2013
P3, N=527, Completed, Sponsor: Astellas Pharma Inc
Active, not recruiting --> Enrolling by invitation Active, not recruiting --> Completed
- | New P1 trial: Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients (clinicaltrials.gov) - Apr 25, 2013
P1, N=24, Completed, Sponsor: Meiji Seika Pharma Co., Ltd.
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Trial withdrawal: Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN) (clinicaltrials.gov) - Apr 24, 2013
P2, N=0, Withdrawn, Sponsor: Loyola University
Active, not recruiting --> Completed Terminated --> Withdrawn
- Enrollment change: Herpevac Neonatal Substudy (clinicaltrials.gov) - Apr 24, 2013
P=N/A, N=6, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Terminated --> Withdrawn N=50 --> 6
- ||||| AMG 108 / AstraZeneca
New P2a trial: Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa (clinicaltrials.gov) - Apr 22, 2013
P2a, N=100, Recruiting, Sponsor: AstraZeneca
- Enrollment change: Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis (clinicaltrials.gov) - Mar 30, 2013
P3, N=42, Completed, Sponsor: Prof. Yuen Chun-Wah
N=50 --> 6 N=100 --> 42
- Trial completion: Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis (clinicaltrials.gov) - Mar 30, 2013
P3, N=42, Completed, Sponsor: Prof. Yuen Chun-Wah
N=100 --> 42 Recruiting --> Completed
- Clinical: Pilot Study to Evaluate Plasma Treatment of Onychomycosis (clinicaltrials.gov) - Mar 25, 2013
P=N/A, N=15, Recruiting, Sponsor: Moe Medical Devices
- mupirocin / Generic mfg.
Trial initiation date: HOME2DS: Individualized vs. Household MRSA Decolonization (clinicaltrials.gov) - Mar 20, 2013
P=N/A, N=600, Enrolling by invitation, Sponsor: Washington University School of Medicine
Recruiting --> Completed Initiation date: Jan 2013 --> Apr 2013
- famciclovir / Generic mfg.
Trial completion: Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes (clinicaltrials.gov) - Mar 18, 2013
P=N/A, N=42, Completed, Sponsor: Holdsworth House Medical Practice
Initiation date: Jan 2013 --> Apr 2013 Active, not recruiting --> Completed
- mupirocin / Generic mfg.
Clinical: HOME2DS: Individualized vs. Household MRSA Decolonization (clinicaltrials.gov) - Mar 17, 2013
P=N/A, N=600, Enrolling by invitation, Sponsor: Washington University School of Medicine
- New P2 trial: An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) (clinicaltrials.gov) - Mar 17, 2013
P2, N=0, Active, not recruiting, Sponsor: Moberg Derma AB
- | moxidectin / Generic mfg.
Trial completion: Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection (clinicaltrials.gov) - Mar 14, 2013
P3, N=1497, Completed, Sponsor: World Health Organization
Active, not recruiting --> Completed Active, not recruiting --> Completed